Anandamide

Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.

Cross Reference

Introduction

To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Anandamide?

Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Anandamide

MeSH term MeSH ID Detail
Migraine Disorders D008881 11 associated lipids
Morphine Dependence D009021 9 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Muscle Spasticity D009128 5 associated lipids
Mycoses D009181 18 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Neoplasms D009369 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Nerve Degeneration D009410 53 associated lipids
Nervous System Diseases D009422 37 associated lipids
Per page 10 20 50 100 | Total 105

PubChem Associated disorders and diseases

What pathways are associated with Anandamide

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Anandamide?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Anandamide?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Anandamide?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Anandamide?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Anandamide?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Anandamide

Download all related citations
Per page 10 20 50 100 | Total 2222
Authors Title Published Journal PubMed Link
Andrianova EL et al. In vitro effects of anandamide and prostamide e2 on normal and transformed nerve cells. 2011 Bull. Exp. Biol. Med. pmid:22442796
Weller K et al. TRPV1, TRPA1, and CB1 in the isolated vagus nerve--axonal chemosensitivity and control of neuropeptide release. 2011 Neuropeptides pmid:21868092
Aberturas MR et al. Anandamide-loaded nanoparticles: preparation and characterization. 2011 J Microencapsul pmid:21425945
Pinar-Sueiro S et al. [Cannabinoid applications in glaucoma]. 2011 Arch Soc Esp Oftalmol pmid:21414525
Mukhopadhyay B et al. Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver. 2011 Proc. Natl. Acad. Sci. U.S.A. pmid:21383171
Rossi S et al. Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis. 2011 Brain Behav. Immun. pmid:21473912
Gamaleddin I et al. The selective anandamide transport inhibitor VDM11 attenuates reinstatement of nicotine seeking behaviour, but does not affect nicotine intake. 2011 Br. J. Pharmacol. pmid:21501143
Di Marzo V Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight. 2011 Nat. Neurosci. pmid:21187849
Bari M et al. The manifold actions of endocannabinoids on female and male reproductive events. 2011 Front Biosci (Landmark Ed) pmid:21196184
Guindon J et al. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain. 2011 Br. J. Pharmacol. pmid:21198549
Liao YS et al. [Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts]. 2011 Zhonghua Zhong Liu Za Zhi pmid:21575494
Shekhar C Mixed signals: cannabinoid system offers new therapeutic possibilities as well as challenges. 2011 Chem. Biol. pmid:21609833
Hutchins HL et al. Eicosapentaenoic acid decreases expression of anandamide synthesis enzyme and cannabinoid receptor 2 in osteoblast-like cells. 2011 J. Nutr. Biochem. pmid:20951563
Mestre L et al. Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1) receptors. 2011 J Neuroinflammation pmid:21851608
Feledziak M et al. SAR and LC/MS studies of β-lactamic inhibitors of human fatty acid amide hydrolase (hFAAH): evidence of a nonhydrolytic process. 2011 J. Med. Chem. pmid:21899370
Palermo G et al. Covalent inhibitors of fatty acid amide hydrolase: a rationale for the activity of piperidine and piperazine aryl ureas. 2011 J. Med. Chem. pmid:21830831
Johannesson M et al. Cloning, purification and characterization of non-human primate 12/15-lipoxygenases. 2010 Feb-Mar Prostaglandins Leukot. Essent. Fatty Acids pmid:20106647
Davies JW et al. Pharmacology of capsaicin-, anandamide-, and N-arachidonoyl-dopamine-evoked cell death in a homogeneous transient receptor potential vanilloid subtype 1 receptor population. 2010 Br J Anaesth pmid:20354008
Greco R et al. Alterations of the endocannabinoid system in an animal model of migraine: evaluation in cerebral areas of rat. 2010 Cephalalgia pmid:19515121
Correa F et al. Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB. 2010 Glia pmid:19565660
Amorós I et al. Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner. 2010 J. Mol. Cell. Cardiol. pmid:19616555
Falenski KW et al. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration. 2010 Neuropsychopharmacology pmid:20357755
Wu WJ et al. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells]. 2010 Zhonghua Gan Zang Bing Za Zhi pmid:20380798
Hoot MR et al. Chronic constriction injury reduces cannabinoid receptor 1 activity in the rostral anterior cingulate cortex of mice. 2010 Brain Res. pmid:20380816
Fisar Z Inhibition of monoamine oxidase activity by cannabinoids. 2010 Naunyn Schmiedebergs Arch. Pharmacol. pmid:20401651
Nallendran V et al. The plasma levels of the endocannabinoid, anandamide, increase with the induction of labour. 2010 BJOG pmid:20406230
Kobayashi N and Yamamoto Y Hypoxic responses of arterial chemoreceptors in rabbits are primarily mediated by leak K channels. 2010 Adv. Exp. Med. Biol. pmid:20217348
Roser P et al. Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists. 2010 World J. Biol. Psychiatry pmid:20218784
Musella A et al. Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum. 2010 Neuroscience pmid:20219639
Caraceni P et al. Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis. 2010 Liver Int. pmid:19840245
Pratt-Hyatt M et al. Effects of a commonly occurring genetic polymorphism of human CYP3A4 (I118V) on the metabolism of anandamide. 2010 Drug Metab. Dispos. pmid:20702771
Buznikov GA et al. A putative 'pre-nervous' endocannabinoid system in early echinoderm development. 2010 Dev. Neurosci. pmid:19907129
Sagar DR et al. Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain. 2010 Arthritis Rheum. pmid:20722027
Kaczocha M et al. Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2. 2010 J. Biol. Chem. pmid:19926788
Jiang S et al. Endocannabinoids are expressed in bone marrow stromal niches and play a role in interactions of hematopoietic stem and progenitor cells with the bone marrow microenvironment. 2010 J. Biol. Chem. pmid:20826813
Linsalata M et al. Effects of anandamide on polyamine levels and cell growth in human colon cancer cells. 2010 Anticancer Res. pmid:20682986
Aquila S et al. Human sperm anatomy: ultrastructural localization of the cannabinoid1 receptor and a potential role of anandamide in sperm survival and acrosome reaction. 2010 Anat Rec (Hoboken) pmid:19938110
Osman NA et al. Synthesis, binding studies and molecular modeling of novel cannabinoid receptor ligands. 2010 Bioorg. Med. Chem. pmid:21074998
Wiley JL and Burston JJ Chronic Delta9-tetrahydrocannabinol during adolescence increases sensitivity to subsequent cannabinoid effects in delayed nonmatch-to-position in rats. 2010 Pharmacol. Biochem. Behav. pmid:19941884
Piccinetti CC et al. Anandamide and AM251, via water, modulate food intake at central and peripheral level in fish. 2010 Gen. Comp. Endocrinol. pmid:19800340
Catani MV et al. Anandamide extends platelets survival through CB(1)-dependent Akt signaling. 2010 Cell. Mol. Life Sci. pmid:19936621
Xie S et al. Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2. 2010 Chem. Res. Toxicol. pmid:21049984
Banni S and Di Marzo V Effect of dietary fat on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood. 2010 Mol Nutr Food Res pmid:20013888
Amoako AA et al. Quantitative analysis of anandamide and related acylethanolamides in human seminal plasma by ultra performance liquid chromatography tandem mass spectrometry. 2010 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:21056015
Godlewski G et al. Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects. 2010 Chem. Biol. pmid:21095576
Ziegler CG et al. Expression and function of endocannabinoid receptors in the human adrenal cortex. 2010 Horm. Metab. Res. pmid:19862666
Herrera-Solís A et al. Acute and subchronic administration of anandamide or oleamide increases REM sleep in rats. 2010 Pharmacol. Biochem. Behav. pmid:20056119
Malinowska B et al. Involvement of central beta2-adrenergic, NMDA and thromboxane A2 receptors in the pressor effect of anandamide in rats. 2010 Naunyn Schmiedebergs Arch. Pharmacol. pmid:20198363
Romigi A et al. Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy. 2010 Epilepsia pmid:19817812
Di Marzo V Anandamide serves two masters in the brain. 2010 Nat. Neurosci. pmid:21102567
Zakrzeska A et al. A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats. 2010 Br. J. Pharmacol. pmid:20105178
Bardell TK and Barker EL Activation of TRPC6 channels promotes endocannabinoid biosynthesis in neuronal CAD cells. 2010 Neurochem. Int. pmid:20466028
Naccarato M et al. Possible Anandamide and Palmitoylethanolamide involvement in human stroke. 2010 Lipids Health Dis pmid:20470384
Muccioli GG Endocannabinoid biosynthesis and inactivation, from simple to complex. 2010 Drug Discov. Today pmid:20304091
Laezza C et al. Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. 2010 Endocr. Relat. Cancer pmid:20304978
Makwana R et al. Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation. 2010 Br. J. Pharmacol. pmid:20233228
Kozono S et al. Involvement of the endocannabinoid system in periodontal healing. 2010 Biochem. Biophys. Res. Commun. pmid:20233580
Yang YY et al. Mechanisms of TNFalpha-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNFalpha and endocannabinoids. 2010 J. Hepatol. pmid:20626112
Lisboa SF et al. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning. 2010 Int. J. Neuropsychopharmacol. pmid:20587131
Thors L et al. Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase. 2010 Br. J. Pharmacol. pmid:20590565
Mukhopadhyay P et al. CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model. 2010 Br. J. Pharmacol. pmid:20590569
Rajesh M et al. Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells. 2010 Br. J. Pharmacol. pmid:20590572
Wheal AJ et al. Vasorelaxation to N-oleoylethanolamine in rat isolated arteries: mechanisms of action and modulation via cyclooxygenase activity. 2010 Br. J. Pharmacol. pmid:20590573
Gutierrez-Lopez MD et al. Involvement of 2-arachidonoyl glycerol in the increased consumption of and preference for ethanol of mice treated with neurotoxic doses of methamphetamine. 2010 Br. J. Pharmacol. pmid:20590579
Soneji ND et al. Effects of cannabinoids on capsaicin receptor activity following exposure of primary sensory neurons to inflammatory mediators. 2010 Life Sci. pmid:20598325
Patsos HA et al. The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells. 2010 Int. J. Oncol. pmid:20514410
Maccarrone M et al. Intracellular trafficking of anandamide: new concepts for signaling. 2010 Trends Biochem. Sci. pmid:20570522
Fernandez-Solari J et al. Participation of the endocannabinoid system in lipopolysaccharide-induced inhibition of salivary secretion. 2010 Arch. Oral Biol. pmid:20542488
Bhaskaran MD and Smith BN Cannabinoid-mediated inhibition of recurrent excitatory circuitry in the dentate gyrus in a mouse model of temporal lobe epilepsy. 2010 PLoS ONE pmid:20498848
Lam PM et al. Simultaneous measurement of three N-acylethanolamides in human bio-matrices using ultra performance liquid chromatography-tandem mass spectrometry. 2010 Anal Bioanal Chem pmid:20835819
Sántha P et al. The endogenous cannabinoid anandamide inhibits transient receptor potential vanilloid type 1 receptor-mediated currents in rat cultured primary sensory neurons. 2010 Acta Physiol Hung pmid:20511124
Talevi R et al. Is there a role for endocannabinoids in sperm-oviduct interaction? 2010 Reproduction pmid:20511399
Muccioli GG et al. The endocannabinoid system links gut microbiota to adipogenesis. 2010 Mol. Syst. Biol. pmid:20664638
Suárez J et al. Endocannabinoid system in the adult rat circumventricular areas: an immunohistochemical study. 2010 J. Comp. Neurol. pmid:20533360
Clapper JR et al. Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. 2010 Nat. Neurosci. pmid:20852626
Jenkin KA et al. Role for cannabinoid receptors in human proximal tubular hypertrophy. 2010 Cell. Physiol. Biochem. pmid:21220919
Onnis V et al. Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors. 2010 J. Med. Chem. pmid:20143779
Bhaskaran MD and Smith BN Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy. 2010 Exp. Neurol. pmid:20144892
Alptekin A et al. The effects of anandamide transport inhibitor AM404 on voltage-dependent calcium channels. 2010 Eur. J. Pharmacol. pmid:20171208
Snider NT et al. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications. 2010 Pharmacol. Rev. pmid:20133390
Moreno-Galindo EG et al. Molecular basis for a high-potency open-channel block of Kv1.5 channel by the endocannabinoid anandamide. 2010 Mol. Pharmacol. pmid:20133392
Weis F et al. Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure. 2010 J. Mol. Cell. Cardiol. pmid:19931541
Ribeiro A et al. Anandamide prior to sensitization increases cell-mediated immunity in mice. 2010 Int. Immunopharmacol. pmid:20093200
Cencioni MT et al. Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. 2010 PLoS ONE pmid:20098669
Pamplona FA et al. Aspirin-triggered lipoxin induces CB1-dependent catalepsy in mice. 2010 Neurosci. Lett. pmid:20036315
Oz M et al. The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism. 2010 J. Neurochem. pmid:20050977
Yang Q et al. Anandamide induces cell death through lipid rafts in hepatic stellate cells. 2010 J. Gastroenterol. Hepatol. pmid:20059638
Sang N et al. Anandamide potentiation of miniature spontaneous excitatory synaptic transmission is mediated via IP3 pathway. 2010 Neurochem. Int. pmid:20064571
Aquila S et al. Rimonabant (SR141716) induces metabolism and acquisition of fertilizing ability in human sperm. 2010 Br. J. Pharmacol. pmid:20067470
Marczylo TH et al. Anandamide levels in human female reproductive tissues: solid-phase extraction and measurement by ultraperformance liquid chromatography tandem mass spectrometry. 2010 Anal. Biochem. pmid:20026294
Touriño C et al. FAAH deficiency promotes energy storage and enhances the motivation for food. 2010 Int J Obes (Lond) pmid:20029375
Yoshida R et al. Endocannabinoids selectively enhance sweet taste. 2010 Proc. Natl. Acad. Sci. U.S.A. pmid:20080779
Ligresti A et al. Exploiting nanotechnologies and TRPV1 channels to investigate the putative anandamide membrane transporter. 2010 PLoS ONE pmid:20422025
Annuzzi G et al. Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients. 2010 Lipids Health Dis pmid:20426869
El-Talatini MR et al. The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle. 2010 Fertil. Steril. pmid:19200965
Cozzolino R et al. A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis. 2010 Invest New Drugs pmid:19189054
Mukhopadhyay P et al. CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes. 2010 Cardiovasc. Res. pmid:19942623
Barana A et al. Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner. 2010 Cardiovasc. Res. pmid:19689982
Gratzke C et al. Localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity. 2010 Eur. Urol. pmid:19147270
Prieto D Editorial comment on: localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity. 2010 Eur. Urol. pmid:19147273